CUVL

Clinuvel Pharmaceuticals Ltd.

There isn't enough reported data to score CUVL yet.

CUVL Fundamentals

MetricStatus
Unavailable
Unavailable
Unavailable
Unavailable

There isn't enough reported data to rate CUVL's fundamentals.

CUVL PE Valuation

CUVL has no meaningful PE right now: it lost money over the past year.

CUVL Forward outlook

There aren't enough analyst estimates for CUVL to show an outlook.

CUVL Risk to reward

ScenarioChangePrice
UpsideUnknownโ€”
DownsideUnknownโ€”

Calculated from the latest close: $5.05 on Nov 12.

There is not enough scenario data to assess CUVL's risk to reward.

CUVL Earnings Per Share

CUVL Quarterly Revenue

CUVL Free Cash Flow

CUVL Total Shares

CUVL Net Leverage

CUVL's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

CUVL Weekly Momentum

MetricValueStatus
RSI47.6Neutral
Stochastic7.1Oversold

CUVL's weekly RSI is 48 (neutral) and its Stochastic is 7 (oversold).

CUVL PE vs Healthcare Sector

CUVL has no meaningful PE right now: it lost money over the past year.

CUVL Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$5.335.3% below
20 week MA$6.2019% below

CUVL is in a downtrend: it's below all two of its weekly moving averages, and 19% below its 20-week average.

CUVL Yearly ROI

YearStart priceEnd priceROI
2026 YTD$7.05$5.05-28%

It's down 28% so far in 2026.

Give your agent the market.

Get API key